ArticleJournal of the Chinese Medical Association : JCMA2023

Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.

Chih-Hsuan Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.